Clinical Trial Update: Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates early use of Everolimus to manage cytomegalovirus infections in renal transplant recipients; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Fundação Pró Rim | Conditions: Cytomegalovirus Infections | Phase 4 | Status: UNKNOWN